Stay updated on Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe history page now shows Revision: v3.6.6 instead of v3.6.5, representing a small site update and not a change to the study record content.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedThe footer now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a version update of the site rather than changes to the study history data.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision metadata on the page updated from v3.6.3 to v3.6.4, signaling a new site revision is now in effect. The change reflects a backend/UI version update rather than a modification to the study history content.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page revision label changes from 'Revision: v3.6.2' to 'Revision: v3.6.3', indicating a new site release.SummaryDifference0.0%

- Check78 days agoChange DetectedThe page footer now displays Revision: v3.6.2, replacing the previous v3.6.0. This reflects an update to the page's version metadata.SummaryDifference0.0%

- Check93 days agoChange DetectedThe study record now indicates that it is no longer recruiting participants, clarifying that enrollment has ceased. A new revision marker v3.6.0 was added and the previous marker v3.5.5 was removed, updating the version history of the record.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.